Prognostic Significance of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Tumor-Associated Neutrophils in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-AnalysisJOURNAL OF ORAL PATHOLOGY & MEDICINEIF2.32025-12-010OAAI
IDO1 correlates with the immune landscape of head and neck squamous cell carcinoma: a study based on bioinformatics analysesFRONTIERS IN ORAL HEALTHIF3.12024-04-261OAAI
The effect of matrices on the gene expression profile of patient-derived head and neck carcinoma cells for in vitro therapy testingCANCER CELL INTERNATIONALIF62023-07-240OAAI
High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinomaSCIENTIFIC REPORTSIF3.92021-07-2010OAAI
Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?FRONTIERS IN ONCOLOGYIF3.32021-06-1428OAAI
Evaluation Challenges in the Validation of B7-H3 as Oral Tongue Cancer PrognosticatorHEAD & NECK PATHOLOGYIF4.12020-09-212OAAI
In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patientsEXPERIMENTAL CELL RESEARCHIF3.52019-10-0139OAAI
PCR-based zebrafish model for personalised medicine in head and neck cancerJOURNAL OF TRANSLATIONAL MEDICINEIF7.52019-07-2227OAAI